Eric Lefebvre - Jul 11, 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Medical Officer
Signature
/s/ Mike Ouimette, attorney-in-fact
Stock symbol
PLRX
Transactions as of
Jul 11, 2022
Transactions value $
-$60,000
Form type
4
Date filed
7/13/2022, 07:06 PM
Previous filing
Mar 21, 2022
Next filing
Oct 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Sale -$60K -3K -2.12% $20.00 138K Jul 11, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2020.
F2 Includes 4,356 shares of Common Stock acquired by the reporting person pursuant to an employee stock purchase program.